114 related articles for article (PubMed ID: 9972503)
1. Stability determination of solid lipid nanoparticles (SLN) in aqueous dispersion after addition of electrolyte.
Freitas C; Müller RH
J Microencapsul; 1999; 16(1):59-71. PubMed ID: 9972503
[TBL] [Abstract][Full Text] [Related]
2. Influence of electrolyte and poloxamer 188 on the aggregation kinetics of solid lipid nanoparticles (SLNs).
Wei CC; Ge ZQ
Drug Dev Ind Pharm; 2012 Sep; 38(9):1084-9. PubMed ID: 22181005
[TBL] [Abstract][Full Text] [Related]
3. Nondestructive rheological measurement of aqueous dispersions of solid lipid nanoparticles: effects of lipid types and concentrations on dispersion consistency.
Seetapan N; Bejrapha P; Srinuanchai W; Puttipipatkhachorn S; Ruktanonchai U
Drug Dev Ind Pharm; 2010 Sep; 36(9):1005-15. PubMed ID: 20184417
[TBL] [Abstract][Full Text] [Related]
4. Correlation between long-term stability of solid lipid nanoparticles (SLN) and crystallinity of the lipid phase.
Freitas C; Müller RH
Eur J Pharm Biopharm; 1999 Mar; 47(2):125-32. PubMed ID: 10234536
[TBL] [Abstract][Full Text] [Related]
5. Stability of lipid excipients in solid lipid nanoparticles.
Radomska-Soukharev A
Adv Drug Deliv Rev; 2007 Jul; 59(6):411-8. PubMed ID: 17553589
[TBL] [Abstract][Full Text] [Related]
6. Does the commonly used pH-stat method with back titration really quantify the enzymatic digestibility of lipid drug delivery systems? A case study on solid lipid nanoparticles (SLN).
Heider M; Hause G; Mäder K
Eur J Pharm Biopharm; 2016 Dec; 109():194-205. PubMed ID: 27789354
[TBL] [Abstract][Full Text] [Related]
7. Preserved solid lipid nanoparticles (SLN) at low concentrations do cause neither direct nor indirect cytotoxic effects in peritoneal macrophages.
Schöler N; Zimmermann E; Katzfey U; Hahn H; Müller RH; Liesenfeld O
Int J Pharm; 2000 Mar; 196(2):235-9. PubMed ID: 10699726
[TBL] [Abstract][Full Text] [Related]
8. AFM forces between mica and polystyrene surfaces in aqueous electrolyte solutions with and without gas bubbles.
Saavedra JH; Acuña SM; Toledo PG
J Colloid Interface Sci; 2013 Nov; 410():188-94. PubMed ID: 23998373
[TBL] [Abstract][Full Text] [Related]
9. Characterization of gelation process and drug release profile of thermosensitive liquid lecithin/poloxamer 407 based gels as carriers for percutaneous delivery of ibuprofen.
Djekic L; Krajisnik D; Martinovic M; Djordjevic D; Primorac M
Int J Pharm; 2015 Jul; 490(1-2):180-9. PubMed ID: 26002567
[TBL] [Abstract][Full Text] [Related]
10. Electrolyte- and pH-stabilities of aqueous solid lipid nanoparticle (SLN) dispersions in artificial gastrointestinal media.
Zimmermann E; Müller RH
Eur J Pharm Biopharm; 2001 Sep; 52(2):203-10. PubMed ID: 11522487
[TBL] [Abstract][Full Text] [Related]
11. Solid lipid nanoparticles of diethylcarbamazine citrate for enhanced delivery to the lymphatics: in vitro and in vivo evaluation.
Siram K; Chellan VR; Natarajan T; Krishnamoorthy B; Mohamed Ebrahim HR; Karanam V; Muthuswamy SS; Ranganathan HP
Expert Opin Drug Deliv; 2014 Sep; 11(9):1351-65. PubMed ID: 24847779
[TBL] [Abstract][Full Text] [Related]
12. Effect of sodium chloride on the gelation temperature, gel strength and bioadhesive force of poloxamer gels containing diclofenac sodium.
Yong CS; Choi JS; Quan QZ; Rhee JD; Kim CK; Lim SJ; Kim KM; Oh PS; Choi HG
Int J Pharm; 2001 Sep; 226(1-2):195-205. PubMed ID: 11532582
[TBL] [Abstract][Full Text] [Related]
13. Solid lipid nanoparticles (SLN) of Efavirenz as lymph targeting drug delivery system: Elucidation of mechanism of uptake using chylomicron flow blocking approach.
Makwana V; Jain R; Patel K; Nivsarkar M; Joshi A
Int J Pharm; 2015 Nov; 495(1):439-446. PubMed ID: 26367780
[TBL] [Abstract][Full Text] [Related]
14. Development of protocol for screening the formulation components and the assessment of common quality problems of nano-structured lipid carriers.
Negi LM; Jaggi M; Talegaonkar S
Int J Pharm; 2014 Jan; 461(1-2):403-10. PubMed ID: 24345574
[TBL] [Abstract][Full Text] [Related]
15. Spray-drying of solid lipid nanoparticles (SLN TM).
Freitas C; Müllerä RH
Eur J Pharm Biopharm; 1998 Sep; 46(2):145-51. PubMed ID: 9795036
[TBL] [Abstract][Full Text] [Related]
16. Technology of stable, prolonged-release eye-drops containing Cyclosporine A, distributed between lipid matrix and surface of the solid lipid microspheres (SLM).
Wolska E; Sznitowska M
Int J Pharm; 2013 Jan; 441(1-2):449-57. PubMed ID: 23164704
[TBL] [Abstract][Full Text] [Related]
17. Selection and characterization of suitable lipid excipients for use in the manufacture of didanosine-loaded solid lipid nanoparticles and nanostructured lipid carriers.
Kasongo KW; Pardeike J; Müller RH; Walker RB
J Pharm Sci; 2011 Dec; 100(12):5185-96. PubMed ID: 22020815
[TBL] [Abstract][Full Text] [Related]
18. Composition and effect of salt on rheological and gelation properties of Enterolobium contortisilliquum gum exudate.
Oliveira JD; Silva DA; de Paula RC; Feitosa JP; Paula HC
Int J Biol Macromol; 2001 Jul; 29(1):35-44. PubMed ID: 11429187
[TBL] [Abstract][Full Text] [Related]
19. Improved anti-hyperlipidemic activity of Rosuvastatin Calcium via lipid nanoparticles: Pharmacokinetic and pharmacodynamic evaluation.
Dudhipala N; Veerabrahma K
Eur J Pharm Biopharm; 2017 Jan; 110():47-57. PubMed ID: 27810472
[TBL] [Abstract][Full Text] [Related]
20. Amphotericin B loaded solid lipid nanoparticles (SLNs) and nanostructured lipid carrier (NLCs): physicochemical and solid-solution state characterizations.
Jansook P; Fülöp Z; Ritthidej GC
Drug Dev Ind Pharm; 2019 Apr; 45(4):560-567. PubMed ID: 30632399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
